Ginsenosides in cancer: Targeting cell cycle arrest and apoptosis

• Published in: Chemico-biological interactions 2023-09, Vol.382 (3), p.110634-110634, Article 110634
• Main Authors: Shah, Muhammad Ajmal, Abuzar, Syed Muhammad, Ilyas, Kainat, Qadees, Irtaza, Bilal, Momna, Yousaf, Rimsha, Kassim, Roaa Mohammed Tahir, Rasul, Azhar, Saleem, Uzma, Alves, Maria Silvana, Khan, Haroon, Blundell, Renald, Jeandet, Philippe
• Format: Article
• Language: English
• Subjects: Cancer; Dysregulated metabolism; Environmental Sciences; Ginsenosides; Molecular targets; Natural products
• ISSN: 0009-2797; 1872-7786
• DOI: 10.1016/j.cbi.2023.110634

Despite the existence of extensive clinical research and novel therapeutic treatments, cancer remains undefeated and the significant cause of death worldwide. Cancer is a disease in which growth of cells goes out of control, being also able to invade other parts of the body. Cellular division is strictly controlled by multiple checkpoints like G1/S and G2/M which, when dysregulated, lead to uncontrollable cell division. The current remedies which are being utilized to combat cancer are monoclonal antibodies, chemotherapy, cryoablation, and bone marrow transplant etc. and these have also been greatly disheartening because of their serious adverse effects like hypotension, neuropathy, necrosis, leukemia relapse and many more. Bioactive compounds derived from natural products have marked the history of the development of novel drug therapies against cancer among which ginsenosides have no peer as they target several signaling pathways, which when abnormally regulated, lead to cancer. Substantial research has reported that ginsenosides like Rb1, Rb2, Rb3, Rc, Rd, Rg3, Rh2 etc. can prevent and treat cancer by targeting different pathways and molecules by induction of autophagy, neutralizing ROS, induction of cancerous cell death by controlling the p53 pathway, modulation of miRNAs by decreasing Smad2 expression, regulating Bcl-2 expression by normalizing the NF-Kb pathway, inhibition of inflammatory pathways by decreasing the production of cytokines like IL-8, causing cell cycle arrest by restricting cyclin E1 and CDC2, and induction of apoptosis during malignancy by decreasing β-catenin levels etc. In this review, we have analyzed the anti-cancer therapeutic potential of various ginsenoside compounds in order to consider their possible use in new strategies in the fight against cancer. [Display omitted] •Use of ginsenosides as a possible a new strategy in fighting cancer.•Ginsenosides display anti-cancer activity through regulation of cell cycle and apoptosis.•New dimension of the antitumor effects of ginsenosides in various cancers.